 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper129th MAINE LEGISLATURE
SECOND REGULAR SESSION-2020
Legislative Document No. 2155
H.P. 1543 House of  Representatives, March 17, 2020
An Act  To Prevent  Accidental Overdoses by Establishing a Protocol 
for Prescription Drug Recovery
(AFTER  DEADLINE)
Approved for  introduction by a majority  of the Legislative Council  pursuant to Joint Rule 
205.
Reference to the Committee on Health  Coverage, Insurance and Financial Services 
suggested and ordered printed.
ROBERT  B. HUNT
Clerk
Presented by Representative GRAMLICH of Old Orchard Beach.
Cosponsored by Senator FOLEY of  York and
Representatives: BRENNAN  of Portland, CAMPBELL of Orrington,  CRAVEN of Lewiston,  
McCREA of  Fort Fairfield, O'CONNELL  of Brewer, Senators:  CLAXTON of Androscoggin, 
GRATWICK of Penobscot,  MOORE  of Washington.

Page 1 - 129LR3251(01)-11Be it enacted by the People of the State of Maine as follows:
2Sec. 1.  22 MRSA §7246, sub-§2, as repealed and replaced by PL 2017, c. 360, 
3§1, is amended to read:
42.  Dispenser.  "Dispenser" means:
5A.  A pharmacist who is licensed or registered under Title 32; or
6B.  A veterinarian licensed under Title 32, chapter 71-A with authority to dispense a 
7benzodiazepine or an opioid medication.; or
8C.  An administering provider as defined in section 7351, subsection 1, paragraph A.
9Sec. 2.  22 MRSA §7249, sub-§1, as amended by PL 2017, c. 360, §3, is further 
10amended to read:
111.  Information required.  Except as provided in subsection 1-A or, 1-B or 1-C, each 
12dispenser shall submit to the department, by electronic means or other format specified in 
13a waiver granted by the department, specific items of information regarding dispensed 
14controlled substances determined by the department from the following list:
15A.  The dispenser identification number;
16B.  The date the prescription was filled;
17C.  The prescription number;
18D.  Whether the prescription is new or is a refill;
19E.  The National Drug Code (NDC) for the drug dispensed;
20F.  The quantity dispensed;
21G.  The dosage;
22H.  The patient identification number;
23I.  The patient name;
24J.  The patient address;
25K.  The patient date of birth;
26L.  The prescriber identification number;
27M.  The date the prescription was issued by the prescriber; and
28N.  The department-issued serial number if the department chooses to establish a 
29serial prescription system.
30Sec. 3.  22 MRSA §7249, sub-§1-C is enacted to read:
311-C.  Dispensing by administering providers.  If a controlled substance is 
32dispensed by an administering provider, as defined in section 7351, subsection 1, 
33paragraph A, that administering provider is required to provide only the information 
34required by subsection 1, paragraphs B, D and F to K.
Page 2 - 129LR3251(01)-11Sec. 4.  22 MRSA c. 1627 is enacted to read:
2CHAPTER 1627
3MONITORING AND DISPOSAL OF CONTROLLED SUBSTANCES
4§7351.  Monitoring, containment and disposal of controlled substances
5A provider that administers a controlled substance to an adult with long-term care 
6needs is subject to the requirements of this section.
71.  Definitions.  As used in this section, unless the context otherwise indicates, the 
8following terms have the following meanings.
9A.  "Administering provider" means a provider that administers a controlled 
10substance, pursuant to a prescription, to a client-patient.  "Administering provider" 
11includes an employee or contractor of a provider but does not include a family 
12member of the client-patient.
13B.  "Client-patient" means an adult with long-term care needs to whom an 
14administering provider administers a controlled substance.
15C.  "Controlled substance" has the same meaning as in section 7246, subsection 1.
162.  Monitoring.  An administering provider shall document the quantity and strength 
17of any controlled substance obtained for a client-patient.  The administering provider 
18shall comply with the requirements of the Controlled Substances Prescription Monitoring 
19Program, including the reporting requirements of section 7249, subsection 1, as limited 
20by section 7249, subsection 1-C.
213.  Containment.  An administering provider shall keep any controlled substances 
22prescribed and obtained for a client-patient in a locked container to which only the 
23administering provider, the client-patient and, if there is one, a designated caregiver have 
24access.
254.  Retrieval and disposal of controlled substances; documentation; reporting.  
26Upon the death of a client-patient for whom the administering provider was providing in-
27home and community support services immediately prior to that client-patient's death, the 
28administering provider shall collect all unused controlled substances that were prescribed 
29and obtained for the client-patient.  The administering provider shall document the 
30controlled substances collected, including the National Drug Code, quantity and strength 
31of each controlled substance, properly dispose of the collected controlled substances and 
32document the manner of disposal.  Following disposal, the administering provider shall 
33provide all documentation performed pursuant to this subsection to the department in the 
34same manner as information provided to the department pursuant to section 7249, 
35subsection 1.
365.  Development of written policy; submission for review.  Each administering 
37provider shall develop a written policy for how that administering provider will 
38document, collect and dispose of controlled substances in compliance with the 
39requirements of this chapter.  The administering provider shall submit the policy, 
Page 3 - 129LR3251(01)-11including any changes made to the policy subsequent to initial submission, to the 
2department for review.
36.  Rulemaking.  The department shall adopt routine technical rules, pursuant to Title 
45, chapter 375, subchapter 2-A, to implement the provisions of this chapter, including 
5providing guidance for methods of proper disposal of controlled substances collected 
6pursuant to subsection 4.
7SUMMARY
8This bill seeks to reduce accidental overdose deaths caused by access to unused 
9controlled substances by:
101.  Requiring an entity, agency, facility or individual who offers or plans to offer any 
11in-home or community support services or institutionally based long-term care services 
12and who administers a controlled substance to an adult with long-term care needs as part 
13of those services, referred to in the bill as "an administering provider," to document any 
14controlled substance prescribed and obtained for the adult with long-term care needs, 
15referred to in the bill as "the client-patient," and to participate in the Controlled 
16Substances Prescription Monitoring Program, with certain exceptions;
172.  Requiring that all controlled substances be kept in a locked container to which 
18only the administering provider, the client-patient and, if there is one, a designated 
19caregiver have access; and
203.  Requiring the administering provider, upon the death of the client-patient, to 
21collect any unused controlled substances that were prescribed and obtained for that client-
22patient and dispose of them properly after documenting the National Drug Code, quantity 
23and strength.  The administering provider is required to submit this documentation, 
24including the manner of disposal of the controlled substances collected from the deceased 
25client-patient, to the Department of Health and Human Services using the reporting 
26system established in the Controlled Substances Prescription Monitoring Program.
